Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
It’s #GivingTuesday and we're out to win up to $50,000 in the Newman’s Own Foundation $500k Holiday Challenge. Such an amazing opportunity and we need your help.
The top 3 organizations to raise the most online on #GivingTuesday will each win a cash prize. First place wins $50,000, 2nd place wins $25,000, and 3rd place wins $10,000.
The #GivingTuesday Bonus Challenge ends at 11:59:59 pm ET today, so please Click Here [https://www.crowdrise.com/o/en/campaign/denise-cancergrace] to donate and support our cause before time runs out.
Thank you so much and we really appreciate all of your help.
If you prefer to give directly, to make a tax-deductible donation, go online to cancerGRACE.org/donate today. Thank you!
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…